Downstaging with atezolizumab-bevacizumab: a case series

• Main Authors: Anand V. Kulkarni (Author), Parthasarathy Kumaraswamy (Author), Balachandran Menon (Author), Anuradha Sekaran (Author), Anuhya Rambhatla (Author), Sowmya Iyengar (Author), Manasa Alla (Author), Shantan Venishetty (Author), Sumana Kolar Ramachandra (Author), Giri V. Premkumar (Author), Mithun Sharma (Author), P. Nagaraja Rao (Author), Duvvur Nageshwar Reddy (Author), Amit G. Singal (Author)
• Format: Book
• Published: Korean Liver Cancer Association, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgrounds/Aims Hepatocellular carcinoma (HCC) is generally diagnosed at an advanced stage, which limits curative treatment options for these patients. Locoregional therapy (LRT) is the standard approach to bridge and downstage unresectable HCC for liver transplantation (LT). Atezolizumab-bevacizum...